Authors: Jonathan RT Lakey, C.T. Desire Cox, David Whaley, Kimia Damyar, Michael Alexander, Prof. Dr. Mike K.S. Chan, Prof. Dr. Michelle B.F. Wong, Augusta Wellington, Jason Wooldridge and Ghassan Kassab
Publisher: American Journal of Biomedical Science & Research. 2022 - 16(3)
Publisher URL: http://dx.doi.org/10.34297/AJBSR.2022.16.002236
Authors:Prof. Dr. Mike K.S. Chan, Prof. Dr. Michelle B.F. Wong, Prof. Dr. Thomas Skutella, Dr. Roni Lara Moya and Dr. Dmytro Klokol
Publisher: HSOA, Stem Cells Research Development & Therapy, ISSN:2381-2060
Publisher URL: https://www.heraldopenaccess.us/openaccess/clinical-experience-of-thymic-regeneration-with-thymus-extracts-thymic-peptides-and-stem-cells-in-general-medicine-oncology-and-anti-aging-medicine-a-review
Authors: Dr. Olha Nishkumay, Prof. Dr. Mike K.S. Chan, Yuriy Nalapko, Grygorieva N., KordubailoI., Oleh Nikitin, Rudenko Iu.
Publisher: Cell and Organ Transplantology. 2023; 11(1):4-13
Publisher URL: https://doi.org/10.22494/cot.v11i1.146
Authors: Yanmin Wang, Michael Alexander, Todd Scott, Desiree C. T. Cox, Augusta Wellington, Prof. Dr. Mike K.S. Chan, Prof. Dr. Michelle B.F. Wong, Orn Adalsteinsson and Jonathan R. T. Lakey
Publisher: MDPI peer-reviewed journal Animals 2023, 13(15), 2457
Publisher URL: https://www.mdpi.com/2076-2615/13/15/2457
Authors:Osama Hamadelseed, Prof. Dr. Mike K.S. Chan, Prof. Dr. Michelle B.F. Wong and Prof. Dr. Thomas Skutella
Publisher: Front. Neurosci., Sec. Neurodevelopment, Volume 17 - 2023
Publisher URL: https://doi.org/10.3389/fnins.2023.1225228
Authors: Dr. Olha Nishkumay, Prof. Dr. Mike K.S. Chan, Yuriy Nalapko, H.V. Mostbauer, O.O. Alekseenko, Oleh Nikitin, Ilya Kordubailo
Publisher: PAIN, JOINTS, SPINE, 13(2), 116–125
Authors: Augusta Wellington, Jonathan RT Lakey, Alana Williams, Mike KS Chan, Michelle BF Wong, Marcelle Gisain, Caroline Mosessain, Orn Adalsteinsson and Desiree CT Cox
Publisher: Open Acc J Bio Sci. July-August- 4(4): 1956-1960
Authors: Augusta Wellington, Jonathan RT Lakey, Alana Williams, Mike MK Chan, Michelle BF Wong, Marcelle Gisain, Caroline Mosessain, Orn Adalsteinsson and Desiree CT Cox
Publisher: Open Acc J Bio Sci. July-August- 4(4): 1986-1989
Authors:Junxian Zhou, Kang Liu, Chis Bauer, Gerald Bendner, Heike Dietrich, Jakub Peter Slivka, Michael Wink, Prof. Dr. Michelle B.F. Wong, Prof. Dr. Mike K.S. Chan, Prof. Dr. Thomas Skutella
Publisher: Int. J. Mol. Sci. 2023, 24(7), 6748
Publisher URL: https://doi.org/10.3390/ijms24076748
Autism Spectrum Disorder: Bioregenerative Medicine with Stem Cell Therapy is intended for a wide audience: parents of autistic children, regular and special education teachers, medical specialists, and for everybody who wants to learn about modern approaches to treat developmental diseases. This comprehensive monograph contains broad knowledge starting with a brief history of autism spectrum disorder, theories of occurrence and diagnosis, and reviewing modern behavioural, pharmacological, and bioregenerative therapeutic technologies.
Why is this book different? It is grounded in recent data related to new conceptualizations of the occurrence of autism spectrum disorder which consider autism a mitochondrial disease. Thus, the authors explain core concepts. What is a mitochondrion? How does its damage appear and correlate to the signs and symptoms of autism? What kind of bioregenerative therapies have great therapeutic potential? Almost all therapeutic methods for autism spectrum disorder are discussed from the point of view of the evidence based medicine.
Bioregenerative technology is based on the restoration of damaged subcellular structures like mitochondria and brain cell peptides. Bioregenerative antioxidant therapy, hyperbaric oxygen therapy, transcranial magnetic/direct current stimulation, and mitochondrial organelles replacement therapy are key directions in the treatment of autism spectrum disorder.
Finally, new technology that holds high potential for the restoration of brain function is discussed—bioregenerative stem cell therapy. Because of the strong correlation between the symptoms of autism and changes in the brain, physicians have great tools to regulate such clinical symptoms through stem cell therapy. Most importantly, the authors have personal experience using the stem cell therapy with autism spectrum disorder patients. All facts are strongly supported by published scientific reviews and trials.
Prof. Dato’ Sri Dr. Mike K.S. Chan is an author, educator and pioneer of Organotherapy, Cellular Therapy and Cell Membrane Therapy in Europe and Asia since the early 1980s. He founded and funded one of the world’s largest research on Bio-Molecular and Bio-Regenerative Medicine in Switzerland and Germany, with a global presence in almost eighty countries. He has conducted more than 1,000 lectures, seminars, and symposiums worldwide in the fields of organotherapy, cell therapies, age reversal, regenerative medicine, and stem-cell therapies.
Dr. Yuriy Nalapko, MD, PhD, is an academician and practical medical doctor in Intensive Care, Antiaging, and Bioregenerative Medicine. An area of scientific interest is longevity and how a cell functions with different diseases. He is the author of many handbooks, monographs, and more than 300 articles. Based on his clinical experience, he proposed new approaches to reverse degenerative diseases of the brain, liver, and endocrine organs in different disorders. In Metabolic Disorder Therapy, he combines preventive, pharmacological, and bioregenerative approaches as a state-of-the-art paradigm to correct structural and functional malfunctions.
Dr. Svetlana Yartseva, MD, PhD, is a certified Endocrinologist and Internal Diseases Practitioner. A member of several international associations on the study of diabetes; the European Thyroid Association; and the European Association of Preventive, Regenerative, and Antiaging Medicine; she is a Consultant at numerous private clinics. Her main concern is treatment of patients with obesity, metabolic syndrome, and diabetes mellitus through modern pharmacological and non-pharmacological methods.
Prof. Dato' Sri Dr. Michelle B.F. Wong, ND, PhD is a scientist, researcher and educator actively involved in research and development (R&D) work on stem cells focusing on Fetal Precursor Stem-Cell Therapy. She is the Co-Founder/Senior Technical Advisor and Researcher in FCTI Inc., specialising in Stem cell Research and Bio-Regenerative Medicine for more than three decades. A prominent speaker, Michelle Wong presents at educational programs and global conferences on stem cells, cell therapy and biological medicine for physicians and healthcare practitioners worldwide.